Intensity Therapeutics, Inc.

INTS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$16-$11-$8-$8
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0-$0$0
Stock-Based Comp.$3$1$1$0
Change in WC-$2-$1$1$0
Other Non-Cash$0$3$0$1
Operating Cash Flow-$15-$7-$5-$7
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$3-$15$0$0
Inv. Sales/Matur.$9$9$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$6-$6$0$0
Financing Activities
Debt Repay.$0$0$2$2
Stock Issued$3$22$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$2$0$0
Financing Cash Flow$3$20$2$2
Forex Effect$0$0$0$0
Net Chg. in Cash-$6$7-$3-$5
Supplemental Information
Beg. Cash$9$1$5$9
End Cash$3$9$1$5
Free Cash Flow-$15-$7-$5-$7
Intensity Therapeutics, Inc. (INTS) Financial Statements & Key Stats | AlphaPilot